Thursday, May 14, 2026
CN
  • About
  • Advertise
  • Careers
  • Contact
Money Compass
  • Home
  • Financial News
  • Investment News
  • Other News
    • Bursa News
    • Government News
    • Listing Companies News
    • Oversea Financial & Investment News
  • Interviews
    • Features Interviews
    • Corporate Interviews
  • Financial & Investment Articles
  • PR Newswire
  • Login
No Result
View All Result
Money Compass
Home PR Newswire

Robo.ai Subsidiary Neurovia AI Launches NeuroStream™ Technology Platform to Build Physical AI Visual Data Infrastructure

Money Compass by Money Compass
May 14, 2026
in PR Newswire
0
Robo.ai Subsidiary Neurovia AI Launches NeuroStream™ Technology Platform to Build Physical AI Visual Data Infrastructure
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

DUBAI, UAE, May 14, 2026 /PRNewswire/ — Robo.ai Inc. (Nasdaq: AIIO), announced today that its wholly-owned AI data processing and compression technology subsidiary, Neurovia AI, has officially released its core technology platform, NeuroStream™. Designed for the machine economy era, the platform utilizes a bitmap vectorization algorithm to provide high-fidelity, low-bandwidth, and low-power infrastructure support for the massive visual data generated by physical artificial intelligence. Mansoor Ali Khan, Chief Technology Officer of Neurovia AI, detailed the platform’s technical architecture and application cases.


To demonstrate the practical performance of NeuroStream™, Neurovia AI has published comparative case studies on its official website (https://www.neuroviaai.ae/). According to internal testing, a 5.5GB 4K 60fps original video processed through NeuroStream™ can be compressed to a file size of 278MB, reducing storage space usage by approximately 95%.

Related posts

Datar Cancer Genetics Receives Landmark US FDA Clearance for CellDx-Tissue, a Comprehensive Genomic Profiling Assay for Solid Tumors Using DNA + RNA

Datar Cancer Genetics Receives Landmark US FDA Clearance for CellDx-Tissue, a Comprehensive Genomic Profiling Assay for Solid Tumors Using DNA + RNA

May 14, 2026
Datar Cancer Genetics Receives Landmark US FDA Clearance for CellDx-Tissue, a Comprehensive Genomic Profiling Assay for Solid Tumors Using DNA + RNA

Datar Cancer Genetics Receives Landmark US FDA Clearance for CellDx-Tissue, a Comprehensive Genomic Profiling Assay for Solid Tumors Using DNA + RNA

May 14, 2026

These tests indicate that NeuroStream™ significantly reduces file size while fully retaining core visual information such as the original video’s resolution and frame rate. This visually lossless characteristic ensures that the substantially compressed data continues to provide a clean and complete data source for subsequent machine vision and AI computations. This capability meets the strict data authenticity requirements of industrial, sovereign, and specific legal application scenarios, while also generating clear economic benefits for enterprises in terms of energy consumption, storage space, and processing latency.

Chief Technology Officer Mansoor noted that global unit data storage prices have increased approximately fourfold since 2026. According to industry estimates, every terabyte of data storage saved generates a direct economic benefit of $1,000 to $1,500 annually for an AI customer, in addition to indirect benefits related to transmission efficiency, energy consumption, data integrity, and security.

Through AI-native compression, intelligent visual optimization, and edge computing adaptation, NeuroStream™ converts traditional bitmap logic into a vectorized mathematical expression. This approach lowers transmission and storage costs while precisely preserving the critical visual information necessary for AI computation, offering an effective solution to rising storage expenses.

The platform provides native format compatibility with zero decompression usage costs, as processed images and videos maintain their original formats and can be directly accessed by systems without specific decompression software. This full compatibility with existing conventional video workflows substantially reduces system integration and friction costs for enterprises.

Furthermore, NeuroStream™ optimizes data quality and enhances machine vision recognition accuracy by intelligently improving the data signal-to-noise ratio during processing. This process aids in increasing the computational efficiency of AI algorithms and ensures that machines maintain high recognition accuracy on the compressed data.

Optimized for edge computing, the platform allows standard commercial devices to process hundreds of terabytes of data, facilitating deployment on resource-constrained sensors, drones, and mobile nodes. Furthermore, its independent offline operational capability ensures data privacy, meeting strict compliance standards for sensitive sectors including aerospace, medical imaging, and energy.

Neurovia plans to deploy NeuroStream™ across key sectors, including autonomous driving, robotics, and smart cities. By leveraging the expansion of global edge computing, the platform aims to reduce bandwidth requirements and data center energy consumption. This infrastructure is designed to facilitate efficient, real-time machine vision networks, supporting the broader commercialization of the machine economy.

About Neurovia AI Limited
Neurovia AI (www.neuroviaai.ae) provides AI data processing and visual infrastructure through its NeuroStream™ platform. Dedicated to transitioning visual data from human viewing to machine understanding, the company utilizes AI-native compression and edge computing to address data bottlenecks in Physical AI. Its technology serves autonomous driving, smart cities, and intelligent manufacturing, providing a foundational layer for global machine perception and collaboration.

About Robo.ai Inc.
Robo.ai Inc. (NASDAQ: AIIO) is a technology company dedicated to building an artificial intelligence machine economy platform. Its mission is to integrate smart terminals through AI software, intelligent hardware, and smart assets to construct a unified artificial intelligence operating system and a blockchain-empowered ecosystem to pioneer an intelligent future.

Safe Harbor Statement
This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations; for further details, please refer to the documents the company has filed with the U.S. Securities and Exchange Commission.

Media Contacts
Neurovia AI Corporate Communications
Email: [email protected]
Website: www.neuroviaai.ae 
Robo.ai Inc. Corporate Communications
Email: [email protected]
Website: www.roboai.io

​ 

Previous Post

Miroma Project Factory Supports Sullivans Cove With Launch Of New ‘Navigator’

Next Post

METiS TechBio, the World’s First Publicly Listed AI-Powered Drug Delivery Company, Debuts on the Hong Kong Stock Exchange, “The SpaceX of Pharmaceuticals” Ushers in a New Era of Biopharmaceuticals

Next Post
METiS TechBio, the World’s First Publicly Listed AI-Powered Drug Delivery Company, Debuts on the Hong Kong Stock Exchange, “The SpaceX of Pharmaceuticals” Ushers in a New Era of Biopharmaceuticals

METiS TechBio, the World's First Publicly Listed AI-Powered Drug Delivery Company, Debuts on the Hong Kong Stock Exchange, "The SpaceX of Pharmaceuticals" Ushers in a New Era of Biopharmaceuticals

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

BROWSE BY CATEGORIES

  • Blog
  • Bursa News
  • Corporate Interviews
  • Features Interviews
  • Financial & Investment Articles
  • Financial News
  • Government News
  • Investment News
  • Listing Companies News
  • Oversea Financial & Investment News
  • PR Newswire

BROWSE BY TOPICS

2018 League Balinese Culture Bali United Budget Travel business Champions League Chopper Bike Doctor Terawan industrial Istana Negara Malaysia Market Stories National Exam net zero emissions targets 2025 Renewable energy Visit Bali

Recent News

  • Datar Cancer Genetics Receives Landmark US FDA Clearance for CellDx-Tissue, a Comprehensive Genomic Profiling Assay for Solid Tumors Using DNA + RNA
  • Datar Cancer Genetics Receives Landmark US FDA Clearance for CellDx-Tissue, a Comprehensive Genomic Profiling Assay for Solid Tumors Using DNA + RNA
  • YAS ISLAND TO BE HOME OF SPHERE ABU DHABI, A NEW GLOBAL ICON FOR IMMERSIVE ENTERTAINMENT

Category

  • Blog
  • Bursa News
  • Corporate Interviews
  • Features Interviews
  • Financial & Investment Articles
  • Financial News
  • Government News
  • Investment News
  • Listing Companies News
  • Oversea Financial & Investment News
  • PR Newswire
  • About
  • Advertise
  • Careers
  • Contact

Copyright © 2024 Money Compass Media (M) Sdn Bhd. All Rights Reserved

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Features Interviews
  • Government News
  • Financial News
  • Investment News
  • Listing Companies News
  • Corporate Interviews
  • Bursa News
  • Financial & Investment Articles
  • Oversea Financial & Investment News

Copyright © 2024 Money Compass Media (M) Sdn Bhd. All Rights Reserved